+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Clinical Trial Supply & Logistics for Pharmaceutical Market by Phase, Sector, Therapeutic Area - Forecast 2024-2030- Product Image
Global Clinical Trial Supply & Logistics for Pharmaceutical Market by Phase, Sector, Therapeutic Area - Forecast 2024-2030- Product Image
Sale

Global Clinical Trial Supply & Logistics for Pharmaceutical Market by Phase, Sector, Therapeutic Area - Forecast 2024-2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4989664
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Clinical Trial Supply & Logistics for Pharmaceutical Market size was estimated at USD 22.73 billion in 2023, USD 24.48 billion in 2024, and is expected to grow at a CAGR of 7.75% to reach USD 38.34 billion by 2030.

The clinical trial supply chain is a critical aspect of the pharmaceutical industry, as it involves the storage, distribution, and monitoring of investigational medicinal products (IMPs) used in clinical studies. Clinical trial logistics primarily aim to ensure that the essential resources are available at the right time, place, and under optimal conditions to maintain quality throughout the trial process. Clinical trial supply & logistics plays a vital role in the overall success of drug development programs by directly impacting cost management, risk mitigation, efficiency improvement, and patient safety.

Some major trends contributing to this industry growth include the globalization of clinical trials, the adoption of technology-driven solutions, and the outsourcing of non-core functions within pharmaceutical companies. The growth of the clinical trial supply & logistics (CTSL) market has been significantly influenced by the increasing Research and Development (R&D) expenditure in the pharmaceutical sector. Pharmaceutical R&D is vital in developing innovative drugs and therapies that improve healthcare outcomes worldwide. The continuous expansion in R&D investments has propelled advancements in clinical trial processes, leading to robust growth in the clinical trial supply & logistics industry. The pharmaceutical industry has faced significant challenges due to the escalating drug development costs and clinical trials. These increased expenses have substantially impacted various aspects of the industry, leading to reduced investment by pharmaceutical companies in their clinical trial supply chain management systems. In recent years, the pharmaceutical industry substantially increased in outsourcing clinical trial activities to contract research organizations (CROs) and other third-party service providers. Multiple factors drive this trend, including the need for cost reduction, access to specialized expertise, and the demand for faster drug development processes, which has significantly supplemented growth in the clinical trial supply chain and logistics services.

Regional Insights

Americas has endured a significant position in the pharmaceutical market's clinical trial supply & logistics due to the adoption of technologically advanced products, well-established regulatory agencies, and considerable contract research organizations. The United States is increasingly focusing on generics and biologics, both cost-effective alternatives to traditional pharmaceuticals. The market has witnessed an increase in business growth with rising demand for generic prescription drugs that the FDA has approved to be the equivalent of a brand-name drug in dosage, safety, strength, quality, performance, and intended use.

Asia-Pacific's expanding technology sector and enhancement in the pharmaceutical services in emerging countries such as China, Korea, and India create several growth opportunities for supply chain management solutions. In contrast, countries such as Australia, Japan, and Singapore represent the developed healthcare systems in the region. EMEA clinical trial supply & logistics for the pharmaceutical market has focused on the re-oriented healthcare and pharmaceutical systems to ensure efficient service delivery. The European region represents the developed market, closely following the developed market's technological and healthcare development trends. The European Union (EU) plays a significant role in the pharmaceutical industry and is a substantial trader in pharmaceuticals and medicinal products. Manufacturing and distribution have also become increasingly globalized, with the maintenance of supply & logistics integrity becoming a high priority for ensuring the safety and quality of drugs and devices, increasing demand for next-generation clinical trial supply & logistics.

Market Trends by Segment

  • Phase: Rising inclination toward Phase III trials owing to the need for exponential utility of clinical trial supply & logistics
  • Therapeutic Area: Exponential utility of clinical trial supply & logistics to cater to the ever-growing oncology R&D activities

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Ariceum Therapeutics and Eurofins CDMO Sign a Pharmaceutical Multi-Project Agreement

Ariceum Therapeutics has entered into an agreement with Eurofins CDMO, a leading global Contract Development and Manufacturing Organization, to provide Clinical Trial Supply services.Eurofins CDMO provides various services to Ariceum, including Qualified Person (QP) release of drug substance in Europe, drug substance storage, drug product packaging, cold chain management, and drug product deliveries to investigational sites.

Catalent Completes Expansion of Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities

Catalent, Inc., the provider of clinical trial supply and logistics solutions for the pharmaceutical industry, recently completed a significant expansion to its clinical supply facility in Singapore. With an investment of USD 2.2 million, the facility spans an impressive 31,000 square feet. This expansion includes adding 35 new freezers for ultra-low temperature (ULT) storage and specialized secondary packaging capabilities.

Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China

Parexel recently inaugurated a state-of-the-art clinical trial supply and logistics depot in Suzhou, China. This strategically positioned facility offers local and international biopharmaceutical clients conducting clinical trials in the region prompt access to essential supplies and investigational treatments for global distribution. Equipped with temperature-controlled storage capabilities (-20ºC, 2-8ºC, 15-25ºC, -80ºC), the depot is equipped to handle secondary packaging/labeling, fulfillment/distribution, and drug sourcing, among other services.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supply & Logistics for Pharmaceutical Market, highlighting leading vendors and their innovative profiles. These include Almac Group, AmerisourceBergen Corporation, Bilcare Limited, Biocair International Limited, Catalent, Inc., Clinigen Group PLC, DHL International GmbH by Deutsche Post AG, Eurofins Scientific SE, FedEx Corporation, ICON PLC, Infosys Limited, KLIFO A/S, Lonza Group, Marken, Movianto, N-Side, Parexel International Corporation, PCI Pharma Services, Seveillar Clinical Trial Supplies Pvt. Ltd., SIRO Clinpharm Private Limited, and Thermo Fisher Scientific, Inc.

This research report offers invaluable insights into various crucial aspects of the Clinical Trial Supply & Logistics for Pharmaceutical Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing R&D Expenditure of Pharmaceutical and Biopharmaceutical Industry
5.1.1.2. Increased Focus on Drug Development
5.1.1.3. Globalization of Clinical Trials and Harmonization of Regulations
5.1.2. Restraints
5.1.2.1. Increased Cost of Drug Development and Clinical Trials
5.1.3. Opportunities
5.1.3.1. Outsourcing of Clinical Trial Activity
5.1.3.2. Increased Focus on Generics and Biologics
5.1.3.3. Regulatory Approvals in Emerging Markets
5.1.4. Challenges
5.1.4.1. Logistics Challenges Across Nations
5.2. Market Segmentation Analysis
5.2.1. Phase: Rising inclination toward Phase III trials owing to the need for exponential utility of clinical trial supply & logistics
5.2.2. Therapeutic Area: Exponential utility of clinical trial supply & logistics to cater to the ever-growing oncology R&D activities
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Phase
6.1. Introduction
6.2. BA/BE Studies
6.3. Phase I
6.4. Phase II
6.5. Phase III
6.6. Phase IV
7. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Sector
7.1. Introduction
7.2. Clinical Trial Logistics and Distributions
7.3. Clinical Trial Manufacturing Services
7.4. Clinical Trial Supply Chain Management
8. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Therapeutic Area
8.1. Introduction
8.2. Blood Disorders
8.3. Digestive System Diseases
8.4. Infectious and Immune System Diseases
8.5. Neurological and Mental Disorders
8.6. Oncology
9. Americas Clinical Trial Supply & Logistics for Pharmaceutical Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Clinical Trial Supply & Logistics for Pharmaceutical Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Clinical Trial Supply & Logistics for Pharmaceutical Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Ariceum Therapeutics and Eurofins CDMO Sign a Pharmaceutical Multi-Project Agreement
12.3.2. Catalent Completes Expansion of Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities
12.3.3. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET RESEARCH PROCESS
FIGURE 2. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET DYNAMICS
FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BA/BE STUDIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BA/BE STUDIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL LOGISTICS AND DISTRIBUTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL LOGISTICS AND DISTRIBUTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SUPPLY CHAIN MANAGEMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SUPPLY CHAIN MANAGEMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INFECTIOUS AND IMMUNE SYSTEM DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INFECTIOUS AND IMMUNE SYSTEM DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY NEUROLOGICAL AND MENTAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY NEUROLOGICAL AND MENTAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 59. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 60. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 61. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 62. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 63. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 64. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 65. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 66. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 67. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 68. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 69. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 70. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 71. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 72. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 73. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 74. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 75. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 76. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 77. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 78. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 80. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 82. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 84. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 86. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 87. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 88. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 89. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 90. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 91. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 92. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 93. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 94. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 95. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 96. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 97. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 98. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 99. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 100. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 101. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 102. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 103. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 104. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 105. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 106. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 107. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 108. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 109. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 110. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 111. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 112. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 113. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 114. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 115. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 116. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 117. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 118. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 119. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 120. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 121. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 122. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 123. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 124. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 125. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 126. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 127. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 128. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 129. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 130. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 131. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 132. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 133. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 134. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 135. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 136. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 137. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 138. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 139. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 140. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 141. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 142. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 143. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 144. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 145. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 146. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 147. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 148. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 149. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 150. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 151. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 152. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 153. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 154. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 155. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 156. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 157. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 158. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 167. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 168. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 169. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 170. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 171. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 172. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 173. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 174. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 175. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 176. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 177. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 178. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 179. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 180. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 181. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 182. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 183. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 184. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 185. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 186. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 187. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 188. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 189. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 190. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 191. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 192. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 193. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 194. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 195. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 196. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 197. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 198. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 199. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 200. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 201. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 202. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 203. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 204. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 205. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 206. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 207. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 208. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 209. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 210. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 211. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 212. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 213. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 214. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 215. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 216. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 217. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 218. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 219. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 220. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 221. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 222. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 223. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 224. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 225. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 226. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 227. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 228. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 229. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 230. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 231. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 232. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 233. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 234. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 235. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 236. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 237. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 238. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 239. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 240. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 241. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 242. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 243. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 244. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 246. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 248. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 250. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 252. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 254. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 256. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 257. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 258. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 259. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2023 (USD MILLION)
TABLE 260. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2024-2030 (USD MILLION)
TABLE 261. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 262. SPAIN CLINICAL TRI

Companies Mentioned

  • Almac Group
  • AmerisourceBergen Corporation
  • Bilcare Limited
  • Biocair International Limited
  • Catalent, Inc.
  • Clinigen Group PLC
  • DHL International GmbH by Deutsche Post AG
  • Eurofins Scientific SE
  • FedEx Corporation
  • ICON PLC
  • Infosys Limited
  • KLIFO A/S
  • Lonza Group
  • Marken
  • Movianto
  • N-Side
  • Parexel International Corporation
  • PCI Pharma Services
  • Seveillar Clinical Trial Supplies Pvt. Ltd.
  • SIRO Clinpharm Private Limited
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 24.48 Billion
Forecasted Market Value ( USD ) by 2030 $ 38.34 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Global Clinical Trial Supply & Logistics Market by Services (Comparator Sourcing, Logistics & Distribution, Manufacturing), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, Therapeutic Area, End User - Forecast 2024-2030 - Product Image

Global Clinical Trial Supply & Logistics Market by Services (Comparator Sourcing, Logistics & Distribution, Manufacturing), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, Therapeutic Area, End User - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From
Clinical Trial Supply and Logistics Global Market Report 2024 - Product Image

Clinical Trial Supply and Logistics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Clinical Trial Supplies Global Market Report 2024 - Product Image

Clinical Trial Supplies Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology), End User (Pharma, Biotech, CROs), & Region - Forecast to 2028 - Product Image

Global Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology), End User (Pharma, Biotech, CROs), & Region - Forecast to 2028

  • Report
  • 328 Pages
  • Global
From
Clinical Trial Supply and Logistics Market for Pharma 2023-2033 - Product Image

Clinical Trial Supply and Logistics Market for Pharma 2023-2033

  • Report
  • 258 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.